GlassScriptPhysician profile
Sohee G Williams
NPI 1700015062
$743.05
in general payments reported to CMS, 2019-2025
20 companies · $47.92 in 2025
The $47.92 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $28.67 · 2022: $59.44 · 2023: $158 · 2024: $121 · 2025: $47.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $141.73 | 2019 | |
| Biogen, INC. | $92.31 | 2024 | Zurzuvae |
| Coopersurgical, INC. | $57.97 | 2019-2023 | Paragard T 380a |
| Abbvie INC. | $51.40 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $42.91 | 2019 | |
| Monaghan Medical Corporation | $40.63 | 2023 | Aerochamber |
| Merck Sharp & Dohme LLC | $29.76 | 2019 | |
| Astellas Pharma US INC | $29.16 | 2024 | Veozah |
| Myovant Sciences INC. | $28.31 | 2022 | |
| Hologic Sales and Service, LLC | $28.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.99 | 2025 | |
| Sumitomo Pharma America, INC. | $23.93 | 2025 | Myfembree |
| Aspira Women'S Health INC | $23.23 | 2023 | Ova1 |
| Pacira Pharmaceuticals Incorporated | $23.05 | 2023 | Exparel |
| Baxter Healthcare | $21.80 | 2023 | Adept |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.00 | 2019 | |
| Organon LLC | $17.94 | 2023 | Nexplanon |
| Minerva Surgical, INC | $17.50 | 2023 | |
| Pfizer INC. | $15.20 | 2022 | |
| Allergan, INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohee Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.